Elanco Animal Health [ELAN] vs Viatris [VTRS] Detailed Stock Comparison

Elanco Animal Health Inc.

NYSE
Loading...

Viatris Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Elanco Animal Health Inc. wins in 6 metrics, Viatris Inc. wins in 14 metrics, with 0 ties. Viatris Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Elanco Animal Health Inc. Viatris Inc. Better
P/E Ratio (TTM) 377.14 235.80 Viatris Inc.
Price-to-Book Ratio 1.72 1.15 Viatris Inc.
Debt-to-Equity Ratio 67.89 99.91 Elanco Animal Health Inc.
PEG Ratio 0.14 -7.80 Elanco Animal Health Inc.
EV/EBITDA 16.68 7.62 Viatris Inc.
Profit Margin (TTM) -4.92% -24.58% Elanco Animal Health Inc.
Operating Margin (TTM) 2.27% 7.78% Viatris Inc.
EBITDA Margin (TTM) 2.27% 7.78% Viatris Inc.
Return on Equity -3.67% -21.08% Elanco Animal Health Inc.
Return on Assets (TTM) 1.25% 1.96% Viatris Inc.
Free Cash Flow (TTM) $284.00M $1.85B Viatris Inc.
Dividend Yield N/A 4.02% N/A
1-Year Return 75.02% 84.75% Viatris Inc.
Price-to-Sales Ratio (TTM) 2.39 1.20 Viatris Inc.
Enterprise Value $15.14B $30.17B Viatris Inc.
EV/Revenue Ratio 3.21 2.11 Viatris Inc.
Gross Profit Margin (TTM) 51.49% 30.99% Elanco Animal Health Inc.
Revenue per Share (TTM) $10 $12 Viatris Inc.
Earnings per Share (Diluted) $-0.47 $-3.00 Elanco Animal Health Inc.
Beta (Stock Volatility) 1.88 0.82 Viatris Inc.
Short % of Float 8.13% 2.77% Viatris Inc.

Elanco Animal Health Inc. vs Viatris Inc. Stock Performance Analysis

Loading Price Chart...

ELAN
VTRS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Elanco Animal Health Inc.0.50%2.58%22.31%3.80%11.94%7.86%
Viatris Inc.-0.97%2.45%-0.97%20.80%39.97%30.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Elanco Animal Health Inc.75.02%133.08%-30.33%-29.12%-29.12%-29.12%
Viatris Inc.84.75%60.16%15.57%-63.39%-26.00%-21.07%

Performance & Financial Health Analysis: Elanco Animal Health Inc. vs Viatris Inc.

MetricELANVTRS
Market Information
Market Cap i$11.18B$16.99B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i4,096,5399,279,279
90 Day Avg. Volume i5,352,8909,383,220
Last Close$24.29$16.32
52 Week Range$13.16 - $27.72$8.63 - $17.53
% from 52W High-12.37%-6.90%
All-Time High$37.61 (Sep 24, 2018)$76.69 (Apr 20, 2015)
% from All-Time High-35.42%-78.72%
Growth Metrics
Quarterly Revenue Growth0.12%0.05%
Quarterly Earnings Growth0.12%0.05%
Financial Health
Profit Margin (TTM) i-0.05%-0.25%
Operating Margin (TTM) i0.02%0.08%
Return on Equity (TTM) i-0.04%-0.21%
Debt to Equity (MRQ) i67.8999.91
Cash & Liquidity
Book Value per Share (MRQ)$13.17$12.78
Cash per Share (MRQ)$1.10$1.31
Operating Cash Flow (TTM) i$560.00M$2.32B
Levered Free Cash Flow (TTM) i$559.75M$2.43B
Dividends
Last 12-Month Dividend Yield iN/A4.02%
Last 12-Month Dividend iN/A$0.60

Valuation & Enterprise Metrics Analysis: Elanco Animal Health Inc. vs Viatris Inc.

MetricELAN (Apr 23, 2026)VTRS (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i377.14235.80
Forward P/E i19.355.54
PEG Ratio i0.14-7.80
Price to Sales (TTM) i2.391.20
Price to Book (MRQ) i1.721.15
Market Capitalization
Market Capitalization i$11.18B$16.99B
Enterprise Value i$15.14B$30.17B
Enterprise Value Metrics
Enterprise to Revenue i3.212.11
Enterprise to EBITDA i16.687.62
Risk & Other Metrics
Beta i1.880.82
Book Value per Share (MRQ) i$13.17$12.78

Financial Statements Comparison: Elanco Animal Health Inc. vs Viatris Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricELAN (2025)VTRS (2025)
Revenue/Sales i4.72B14.30B
Cost of Goods Sold i2.12B9.29B
COGS % of Revenue i45.0%64.9%
Gross Profit i2.59B5.01B
Gross Margin i55.0%35.1%
Research & Development i368.00M965.90M
Operating Income (EBIT) i252.00M253.50M
Operating Margin i5.3%1.8%
EBITDA i913.00M2.52B
EBITDA Margin i19.4%17.6%
Pre-Tax Income i-224.00M-3.67B
Pre-Tax Income % of Revenue i-4.8%-25.6%
Income Tax i8.00M-150.10M
Income Tax % of Revenue i0.2%-1.0%
Net Income (Profit) i-232.00M-3.51B
Profit Margin i-4.9%-24.6%

Balance Sheet & Liquidity Metrics

MetricELAN (2025)VTRS (2025)
Cash & Equivalents i545.00M1.32B
Total Current Assets i3.46B9.79B
Total Current Assets % of Revenue i73.3%68.5%
Total Current Liabilities i1.60B7.09B
Total Current Liabilities % of Revenue i33.9%49.6%
Long-Term Debt i3.94B12.66B
Long-Term Debt % of Revenue i83.6%88.5%
Total Shareholders Equity i6.55B14.71B
Retained Earnings i-2.18B-388.30M
Retained Earnings % of Revenue i-46.3%-2.7%
Property, Plant & Equipment i1.33B271.30M

Cash Flow Statement Comparison

MetricELAN (2025)VTRS (2025)
Operating Cash Flow i489.00M-772.70M
Operating Cash Flow % of Revenue i10.4%-5.4%
Capital Expenditures i-276.00M34.90M
Free Cash Flow i284.00M1.85B
FCF Margin i6.0%12.9%
Debt Repayment i-2.92B-100,000
Common Stock Repurchase iN/A-500.50M

Short Interest & Institutional Ownership Analysis

MetricELANVTRS
Shares Short i25.54M32.12M
Short Ratio i4.533.18
Short % of Float i8.13%2.77%
Shares Outstanding i496.98M1.15B
Float Shares i492.68M1.14B
% Held by Insiders i1.19%0.45%
% Held by Institutions i109.45%86.66%
% Held by Public i-10.64%12.89%

Dividend Analysis & Yield Comparison: Elanco Animal Health Inc. vs Viatris Inc.

MetricELANVTRS
Last 12-Month Dividend iN/A$0.60
Last 12-Month Dividend Yield iN/A4.02%
3-Year Avg Annual Dividend iN/A$0.52
3-Year Avg Dividend Yield iN/A1.13%
3-Year Total Dividends iN/A$1.56
Ex-Dividend DateN/AMar 09, 2026